AI assistant
MEDIFAST INC — Director's Dealing 2025
Jun 26, 2025
33899_dirs_2025-06-26_fa615190-bd2d-44d3-b069-64103b8ead73.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2025-06-25
Reporting Person: BROWN JEFFREY J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-25 | Common Stock | A | 11167.542 | — | Acquired | 29128.189 | Direct |
| 2025-06-25 | Common Stock | A | 9449.458 | $13.39 | Acquired | 38577.647 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4232.967 | Indirect |
Footnotes
F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026.
F2: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.
F3: The price per share of $13.39 is based on the 20-day moving average stock price of the Issuer's common stock as of June 6, 2025.
F4: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.